Biotech Dodo

Biotech Dodo

Home
Events Roundup
Healthtech Pigeon
About us at SomX
Archive
About
#70 – Trick or treat?! Discount drugs and the secrets of eternal youth
The coffee break biotech roundup, by SomX.
Nov 1

October 2025

#69 - Collapsing trials, clever pigs & cutthroat exits
The coffee break biotech roundup, by SomX.
Oct 25
#68 – Heatproof bugs, high-yield bonds & herpes vectors
The coffee break biotech roundup, by SomX.
Oct 18
#67 – Assassinations, acquisitions, and autoimmune ambition
The coffee break biotech roundup, by SomX.
Oct 11
#66 – Irish science, cardiac silence, and fibrotic defiance
The coffee break biotech roundup, by SomX.
Oct 4

September 2025

#65 – Feathered dreams and gene therapy schemes
The coffee break biotech roundup, by SomX.
Sep 27
#64 – Frozen funding, vanishing labs, and stem cells for strokes
The coffee break biotech roundup, by SomX.
Sep 20
#63 – Mind the mitochondria: biotech takes aim at Parkinson’s & ALS
The coffee break biotech roundup, by SomX.
Sep 13
#62 - Mind the mozzies: biotech bites back
The coffee break biotech roundup, by SomX.
Sep 6

August 2025

#61 - This little piggy had a transplant
The coffee break biotech roundup, by SomX.
Aug 30
#60 - New approvals, new models, new money
The coffee break biotech roundup, by SomX.
Aug 25
#59 - Cell-ebrate good times, come on!
The coffee break biotech roundup, by SomX.
Aug 18
© 2025 Som.X Limited
Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture